Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 329 entries
View as:

Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04454086 Org: User:
Start: 03/06/19 End: 07/27/21 Due: 07/27/22

Community Awareness, Resources and Education (CARE II) Project: Project 1

Phase: N/A Priority: Normal
NCT ID: NCT02797600 Org: User:
Start: 06/30/11 End: 04/30/15 Due: 04/30/16

The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05102773 Org: User:
Start: 02/10/20 End: 05/05/22 Due: 05/05/23

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03583424 Org: User:
Start: 09/10/18 End: 09/30/21 Due: 09/30/22

Rural Interventions for Screening Effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT02795104 Org: User:
Start: 11/30/16 End: 07/31/20 Due: 07/31/21

A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women

Phase: N/A Priority: Normal
NCT ID: NCT06635005 Org: User:
Start: 10/03/24 End: 12/31/25 Due: 12/31/26

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01729832 Org: User:
Start: 01/10/11 End: 07/31/12 Due: 07/31/13

Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01660152 Org: User:
Start: 09/30/11 End: 07/17/13 Due: 07/17/14

Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02940301 Org: User:
Start: 12/20/16 End: 09/15/25 Due: 09/15/26

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00267696 Org: User:
Start: 11/30/05 End: 12/31/13 Due: 12/31/14

A Gene Hunting Study for Familial Papillary Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02776969 Org: User:
Start: 08/05/98 End: 12/31/26 Due: 12/31/27

Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00201786 Org: User:
Start: 07/31/03 End: 07/31/13 Due: 07/31/14

Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06630442 Org: User:
Start: 02/21/22 End: 11/14/22 Due: 11/14/23

Adherence to Colon Cancer Screening (ACCS)

Phase: N/A Priority: Normal
NCT ID: NCT02112747 Org: User:
Start: 09/30/13 End: 12/31/20 Due: 12/31/21

Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00201721 Org: User:
Start: 07/31/02 End: 09/30/06 Due: 09/30/07

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00418496 Org: User:
Start: 11/08/06 End: 10/31/13 Due: 10/31/14

Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04906200 Org: User:
Start: 06/28/21 End: 08/31/26 Due: 08/31/27

Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients

Phase: N/A Priority: Normal
NCT ID: NCT05716477 Org: User:
Start: 12/23/22 End: 11/30/24 Due: 11/30/25

Ohio Patient Navigator Research Program

Phase: N/A Priority: Normal
NCT ID: NCT01569672 Org: User:
Start: 11/30/06 End: 12/31/20 Due: 12/31/21

Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma

Phase: N/A Priority: Normal
NCT ID: NCT00841555 Org: User:
Start: 02/13/09 End: 11/25/14 Due: 11/25/15

Head and Neck Cancer Patient Symptom and Oncologic Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05243069 Org: User:
Start: 03/31/23 End: 12/31/28 Due: 12/31/29

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Phase: N/A Priority: Normal
NCT ID: NCT04049539 Org: User:
Start: 01/29/21 End: 12/31/25 Due: 12/31/26

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03786354 Org: User:
Start: 01/09/19 End: 12/31/24 Due: 12/31/25

Osimertinib and Tegavivint As First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04780568 Org: User:
Start: 01/18/22 End: 07/31/29 Due: 07/31/30

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06391099 Org: User:
Start: 04/30/25 End: 12/31/26 Due: 12/31/27